Elsevier announces acquisition of Collexis

- Acquisition Accelerates Elsevier's Ability to Help Researchers and Decision-Makers, Establish, Execute and Evaluate Research Strategies and Deliver Higher ROI

Elsevier (http://www.elsevier.com), the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc. (http://www.collexis.com), a leading developer of semantic technology and knowledge discovery software. The combination of Elsevier's content and Collexis' semantic technology will provide institutions and researchers new ways to collaborate, showcase accomplishments and improve grant related workflow efficiencies.

"Elsevier's research performance, planning and funding (PPF) strategy, delivered through our SciVal (http://www.scival.com) suite of research tools and integrated workflow solutions, helps accelerate scientific discovery and improve the social and economic impact of research while improving research driven ROI," said Jay Katzen, Managing Director, Elsevier Science and Technology. "By combining Collexis' solutions that address several PPF pain points across our customer's collaboration, funding and strategic planning initiatives and SciVal, we've created a unique set of solutions that enable Universities and Government agencies to improve research outcomes."

Collexis technology is considered market leading in the academic segment; well architected and thoughtfully developed over time. Main products include:

- Expert Profiler (http://www.collexis.com/products/expertprofiling.htm): helps institutions better expose their research history and capabilities by aggregating the "conceptual fingerprints" of existing published papers. By using historic publishing and citation data to expose unique relationships among people and institutions, Expert Profiler provides senior decision makers with transparency while researchers can use it to identify others with whom to collaborate. - Reviewer Finder (http://www.collexis.com/products/reviewerfinder.htm): helps grant managers identify the best reviewer available by automatically identifying the most highly qualified researcher with the lowest conflict of interest. This solution can reduce the time grant managers spend identifying a reviewer from upwards of a month down to one week. Reviewer Finder won the 2010 SIIA CODiE Award (http://www.siia.net/codies/2010/about.asp) for the Best Solution Integrating Content into Workflow. - Professional Social Networking ( http://www.aipuniphy.org/Portal/Portal.aspx): BiomedExperts.com (http://www.biomedexperts.com/) connects biomedical researchers to each other through the display and analysis of each scientist's co-author network allowing scientists and researchers across organizations to collaborate in new and time-saving ways. - Knowledge Engine and Knowledge Services: Using the Collexis Knowledge Engine, Collexis helps institutions search, index, categorize, trend and match information inside their own custom data for discovery. They build embedded knowledge solutions in integrated workflows for academic, government and corporate clients.

Collexis Holdings, Inc. is headquartered in Columbia, South Carolina with operations in Cologne, Germany and Valparaiso, Chile. The acquisition is effective immediately and terms of the agreement are not being disclosed.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
BMI's influence on disease pathogenesis uncovered in new research